Notably, Adcitmer® was tested both in vitro and in vivo in an MCC xenograft mouse model to determine the efficacy and toxicity of the drug on treatment of CD56-positive Merkel cell lines. This evidence concerns the gene NCAM1 and Merkel cell skin cancer.